Abstract: Vulvar Paget's disease is an extramammary manifestation of Paget's disease, a cutaneous neoplasm that clinically appears as sharply defined erythematous plaques with irregular borders that usually affect apocrine gland-bearing skin. Extramammary Paget's disease (EMPD) of the vulva can remain undiagnosed for years and could be associated with multifocal neoplasms. The current gold standard for the treatment of vulvar EMPD is surgical excision and the Mohs micrographic surgery is the preferred technique used in evaluating the margins of the specimen. The reconstruction of the vulva using suprafascial flaps reduces hospitalization time and complications rate. 
Introduction
Vulvar Paget's disease is an extramammary manifestation of Paget's disease, a cutaneous neoplasm that clinically appears as sharply defined erythematous plaques with irregular borders that usually affect apocrine gland-bearing skin. Extramammary Paget's disease (EMPD) of the vulva tends to remain undiagnosed for years as it is typically misdiagnosed as contact dermatitis, seborrheic dermatitis, tinea cruris, inverse psoriasis, or Bowen's disease [1] . EMPD most commonly affects postmenopausal Caucasian women and accounts for less than 1% of vulvar malignancies. Although rare, it should be considered in the differential diagnosis of any chronic dermatitis of the perineum [1, 2] . While the current gold standard for the treatment of vulvar EMPD is surgical excision, with Mohs micrographic surgery being the preferred technique, recent scientific publications have proposed the use of imiquimod 5% (applied topically) as an alternative for primary EMPD [3, 4] . However, such case reports typically have limited follow-ups compared to classical surgical resection studies [5] . This paper reports the case of a 67-year-old woman with primary vulvar Paget's disease, who was subjected to Mohs micrographic surgery, followed by vulvar reconstruction using the "Lotus Petal" suprafascial flap. resulting in the diagnosis of extramammary Paget's disease (Figure 1) . A subsequent immunohistochemical profile was performed, revealing a positive result for cytokeratin 7 (CK7) and carcinoembryonic antigen (CEA), while negative for S100. There were no pathological findings in either the abdominal and pelvic computed tomography (CT) scan or the mammography. The patient underwent a vulvectomy using the Mohs micrographic surgical technique, performed by an experienced gynecologic surgeon. 
Case Report

Description of surgical procedure
The area of the vulva to be excised was first delimited, taking into account surgical margins of 3 cm (Figure 2) . The vulvectomy was then performed using a monopolar and bipolar electrosurgical device and the biopsy specimen was sent to pathology for an intraoperative study (Figures 3 and 4) . It was concluded that there was an absence of tumor cells in the biopsy specimen. The surgeon then proceeded with designing the suprafascial flap (i.e., in the form of a "lotus petal") as shown in Figure 5 and carried out the vulvoperineal reconstruction. The gluteal-fold flaps were drawn and adapted to the size of the defect (Figure 5 ). The flap, including the deep fascia, was then raised towards the defect and inserted inside the latter (Figure 6) . Finally, the skin closure was completed in two layers. The final result showed no open defects ( Figure 7) . 
Postoperative follow-up
The patient presented no complications post-surgery and was discharged a week later in order to avoid unnecessary movements that might affect the healing process of the surgical wound. A follow-up session took place three weeks later for a post-operative examination and suture removal. The final pathologic analysis of the biopsy specimen revealed a multifocal vulvar Paget's disease, with surgical margins free of tumor as confirmed during the surgery. The patient returned after six weeks for a post-operative follow-up examination and is currently asymptomatic. The result is shown in Figure 8 .
Figure 8. Results three weeks after the surgery
Results
The patient is currently asymptomatic and will return for a clinical evaluation every six months. The follow-up session includes biomarker studies (CEA), as well as an annual abdominal and pelvic CT scans, owing to the high risk of local and/or systemic recurrence of Paget's disease.
Discussion
Paget's disease of the vulva is a rare neoplasm that tends to recur locally. The vulva remains the most frequently affected site, involving as high as 65% of EMPD cases [6] . Crocker described the first case of EMPD in 1889, in which a lesion affecting the penis and scrotum was identical to the nipples' disease described by Paget in 1874 [7] . Paget's disease of the vulva is sub-classified based on the origin of the altered cells: Type 1 -primary vulvar cutaneous origin; Type 2 -originating from an underlying anal or rectal adenocarcinoma; and Type 3 -originating from bladder adenocarcinoma [8] . Vulvar EMPD most commonly affects post-menopausal Caucasian women, although there has been a recent report involving a premenopausal woman [9] . The clinical diagnosis of EMPD is difficult owing to the non-specific characteristics of the disease, with the most common symptom being the manifestation of intense pruritus associated with the appearance of an erythematous plaque with or without lichenification. It is usually multifocal and may appear as normal skin, thus potentially hindering the establishment of resection margins [10] . A skin biopsy of the lesion is mandatory, especially when the pruritus persists despite medical treatment.
Upon clinical suspicion of EMPD, a full body skin examination as well as a lymph node evaluation should be performed owing to the risk of underlying malignancy that may appear in 12%-33% of cases [6] . In addition to an abdominal and pelvic CT scan, as well as a skin biopsy, appropriate evaluations which include Papanicolaou smear, breast examination, and analysis of fecal occult blood are required. Further examinations such as colonoscopy and cystoscopy are required if the aforementioned analyses are not satisfactory [2] . As there were no other pathological outcomes apart from the vulvar lesion, our patient did not undergo the last two procedures.
As for the treatment of vulvar EMPD, surgical excision remains the gold standard, with Mohs micrographic surgery being the preferred technique. It offers the most reliable margin control, adequate tissue preservation, and has the lowest recurrence rates (16%-28%) [11, 12] . However, it is not as highly effective when the disease is clinically asymptomatic and has a skin texture of normal appearance [2] . With respect to the EMPD prognosis in general, it is limited by the multifocal nature of EMPD [8] . Topical treatment using imiquimod 5% has been reported in the past few years with varying results, occasionally yielding remissions in small tumors and in recurrent cases [3, 4, 13] . However, there is a need for larger controlled trials to accurately determine the efficacy, as well as the safety of the imiquimod 5% cream [3, 4] . In this report, our team demonstrated the "lotus petal" suprafascial skin flap technique, as described by Ragoowansi et al. [14] , which is a simple procedure that can be carried out immediately after a radical vulvectomy. This generally improves the aesthetic results as the scar is hidden in a natural crease, and reduces both the rate of complications and the length of hospital stay [15] .
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